Upregulated CD44v9 expression inhibits the invasion of oral squamous cell carcinoma cells

Sunao Sato1, Mutsumi Miyauchi, Mitsuyasu Kato

  • 1Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

Abstract

Insights

Overexpressing CD44v9 in oral squamous cell carcinoma (OSCC) cells reduces their invasive potential. This suggests CD44v9 upregulation may inhibit metastasis and serve as a future cancer treatment target.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Metastasis Research

Background:

  • CD44 is a cell surface molecule crucial for cancer metastasis.
  • Downregulation of CD44 variant 9 (CD44v9) correlates with metastasis in oral squamous cell carcinoma (OSCC).
  • Previous findings indicate reduced CD44v9 expression may increase invasive potential.

Purpose of the Study:

  • To investigate the correlation between CD44v9 expression and invasive potential in OSCC.
  • To determine if CD44v9 overexpression inhibits OSCC cell invasion.

Main Methods:

  • Transfection of the CD44v9 gene into OSCC cell line HSC-4 (low CD44v9 expression).
  • Assessment of invasive potential using cell culture invasion and 3D culture invasion assays.

Main Results:

  • CD44v9 overexpression significantly downregulated the invasive potential of HSC-4 cells.
  • CD44v9-transfected cells showed inhibited invasion into reorganized stroma compared to parent cells in 3D cultures.

Conclusions:

  • Upregulation of CD44v9 expression inhibits OSCC cell invasion, potentially via enhanced cell-cell adhesion.
  • CD44v9 upregulation represents a potential therapeutic target for OSCC treatment.